Literature DB >> 12482325

The anti-apoptotic effect of leukotriene D4 involves the prevention of caspase 8 activation and Bid cleavage.

Katarina Wikström1, Maria Juhas, Anita Sjölander.   

Abstract

We have shown in a previous study that leukotriene D(4) (LTD(4)) signalling increases cell survival and proliferation in intestinal epithelial cells [Ohd, Wikström and Sjölander (2000) Gastroenterology 119, 1007-1018]. This is highly interesting since inflammatory conditions of the bowel are associated with an increased risk of developing colon cancer. The enzyme cyclo-oxygenase 2 (COX-2) is important in this context since it is up-regulated in colon cancer tissues and in tumour cell lines. Treatment with the COX-2-specific inhibitor N -(2-cyclohexyloxy-4-nitrophenyl)methane sulphonamide has been shown previously to cause apoptosis in intestinal epithelial cells. In the present study, we attempted to elucidate the underlying mechanisms and we can now show that a mitochondrial pathway is employed. Inhibition of COX-2 causes release of cytochrome c, as shown by both Western-blot and microscopy studies, and as with apoptosis, this is significantly decreased by LTD(4). Since previous studies showed increased Bcl-2 levels on LTD(4) stimulation, we further studied apoptotic regulation at the mitochondrial level. From this we could exclude the involvement of the anti-apoptotic protein Bcl-X(L) as well as its pro-apoptotic counterpart Bax, since they are not expressed. Furthermore, the activity of the pro-apoptotic protein Bad (Bcl-2/Bcl-X(L)-antagonist, causing cell death) was completely unaffected. However, inhibition of COX-2 caused cleavage of caspase 8 into a 41 kDa fragment associated with activation and caused the appearance of an activated 15 kDa fragment of Bid. This indicates that N -(2-cyclohexyloxy-4-nitrophenyl)methane sulphonamide-induced apoptosis is mediated by the activation of caspase 8, via generation of truncated Bid, and thereafter release of cytochrome c. Interestingly, LTD(4) not only reverses the effects induced by inhibition of COX-2 but also reduces the apoptotic potential by lowering the basal level of caspase 8 activation and truncated Bid generation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12482325      PMCID: PMC1223256          DOI: 10.1042/BJ20021669

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Role of BAX in the apoptotic response to anticancer agents.

Authors:  L Zhang; J Yu; B H Park; K W Kinzler; B Vogelstein
Journal:  Science       Date:  2000-11-03       Impact factor: 47.728

2.  B cell receptor cross-linking triggers a caspase-8-dependent apoptotic pathway that is independent of the death effector domain of Fas-associated death domain protein.

Authors:  L Besnault; N Schrantz; M T Auffredou; G Leca; M F Bourgeade; A Vazquez
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

3.  Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway.

Authors:  M Li; X Wu; X C Xu
Journal:  Clin Cancer Res       Date:  2001-04       Impact factor: 12.531

4.  Apoptotic signaling during initiation of detachment-induced apoptosis ("anoikis") of primary human intestinal epithelial cells.

Authors:  J Grossmann; K Walther; M Artinger; S Kiessling; J Schölmerich
Journal:  Cell Growth Differ       Date:  2001-03

5.  Ubiquitin-mediated degradation of the proapoptotic active form of bid. A functional consequence on apoptosis induction.

Authors:  K Breitschopf; A M Zeiher; S Dimmeler
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

6.  Induction of apoptosis by cyclo-oxygenase-2 inhibitor NS398 through a cytochrome C-dependent pathway in esophageal cancer cells.

Authors:  M Li; X Wu; X C Xu
Journal:  Int J Cancer       Date:  2001-07-15       Impact factor: 7.396

7.  Involvement of FADD and caspase-8 signalling in detachment-induced apoptosis.

Authors:  M Rytömaa; L M Martins; J Downward
Journal:  Curr Biol       Date:  1999-09-23       Impact factor: 10.834

8.  Characterization of the human cysteinyl leukotriene 2 receptor.

Authors:  C E Heise; B F O'Dowd; D J Figueroa; N Sawyer; T Nguyen; D S Im; R Stocco; J N Bellefeuille; M Abramovitz; R Cheng; D L Williams; Z Zeng; Q Liu; L Ma; M K Clements; N Coulombe; Y Liu; C P Austin; S R George; G P O'Neill; K M Metters; K R Lynch; J F Evans
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

9.  Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155.

Authors:  J M Lizcano; N Morrice; P Cohen
Journal:  Biochem J       Date:  2000-07-15       Impact factor: 3.857

Review 10.  Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c.

Authors:  S J Korsmeyer; M C Wei; M Saito; S Weiler; K J Oh; P H Schlesinger
Journal:  Cell Death Differ       Date:  2000-12       Impact factor: 15.828

View more
  3 in total

1.  Glycogen synthase kinase-3β is a prosurvival signal for the maintenance of human mast cell homeostasis.

Authors:  Madeleine Rådinger; Daniel Smrž; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  J Immunol       Date:  2011-10-28       Impact factor: 5.422

Review 2.  Focus on cutaneous and uveal melanoma specificities.

Authors:  Charlotte Pandiani; Guillaume E Béranger; Justine Leclerc; Robert Ballotti; Corine Bertolotto
Journal:  Genes Dev       Date:  2017-04-15       Impact factor: 11.361

Review 3.  Cysteinyl Leukotriene Pathway and Cancer.

Authors:  Ming-Ju Tsai; Wei-An Chang; Cheng-Hao Chuang; Kuan-Li Wu; Chih-Hung Cheng; Chau-Chyun Sheu; Ya-Ling Hsu; Jen-Yu Hung
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.